These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12784059)

  • 1. Molecular skin barrier models and some central problems for the understanding of skin barrier structure and function.
    Norlén L
    Skin Pharmacol Appl Skin Physiol; 2003; 16(4):203-11. PubMed ID: 12784059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin barrier structure and function: the single gel phase model.
    Norlén L
    J Invest Dermatol; 2001 Oct; 117(4):830-6. PubMed ID: 11676819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin deep.
    Hadgraft J
    Eur J Pharm Biopharm; 2004 Sep; 58(2):291-9. PubMed ID: 15296956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The barrier function of normal skin. Morphologic and functional aspects of the skin barrier].
    Gruber R; Schmuth M
    Hautarzt; 2014 Mar; 65(3):234-40. PubMed ID: 24622852
    [No Abstract]   [Full Text] [Related]  

  • 5. Microneedles: a valuable physical enhancer to increase transdermal drug delivery.
    Escobar-Chávez JJ; Bonilla-Martínez D; Villegas-González MA; Molina-Trinidad E; Casas-Alancaster N; Revilla-Vázquez AL
    J Clin Pharmacol; 2011 Jul; 51(7):964-77. PubMed ID: 21148047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced skin permeability for transdermal drug delivery: physiopathological and physicochemical considerations.
    Xu P; Chien YW
    Crit Rev Ther Drug Carrier Syst; 1991; 8(3):211-36. PubMed ID: 1954651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transdermal drug delivery system and transcutaneous absorption.
    Morimoto Y; Sugibayashi K; Natsume H
    Acta Derm Venereol Suppl (Stockh); 1994; 185():15-7. PubMed ID: 8091920
    [No Abstract]   [Full Text] [Related]  

  • 8. Skin biology.
    Hwa C; Bauer EA; Cohen DE
    Dermatol Ther; 2011; 24(5):464-70. PubMed ID: 22353152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An insight into the role of barrier related skin proteins.
    Wato K; Hara T; Yamana K; Nakao H; Inagi T; Terada K
    Int J Pharm; 2012 May; 427(2):293-8. PubMed ID: 22366484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the human skin barrier--towards a better understanding of dermal absorption.
    Jepps OG; Dancik Y; Anissimov YG; Roberts MS
    Adv Drug Deliv Rev; 2013 Feb; 65(2):152-68. PubMed ID: 22525516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural products as potential drug permeation enhancer in transdermal drug delivery system.
    Patil UK; Saraogi R
    Arch Dermatol Res; 2014 Jul; 306(5):419-26. PubMed ID: 24481830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicologic implications of cutaneous barriers: a molecular, cellular, and anatomical overview.
    Karan A; Alikhan A; Maibach HI
    J Appl Toxicol; 2009 Oct; 29(7):551-9. PubMed ID: 19629956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport efficiency in transdermal drug delivery: What is the role of fluid microstructure?
    Liuzzi R; Carciati A; Guido S; Caserta S
    Colloids Surf B Biointerfaces; 2016 Mar; 139():294-305. PubMed ID: 26799505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors.
    Tsai JC; Guy RH; Thornfeldt CR; Gao WN; Feingold KR; Elias PM
    J Pharm Sci; 1996 Jun; 85(6):643-8. PubMed ID: 8773963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current understanding of skin barrier morphology.
    Norlén L
    Skin Pharmacol Physiol; 2013; 26(4-6):213-6. PubMed ID: 23921107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
    Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
    J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Percutaneous absorption].
    Lafforgue C; Marty JP
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S18-23. PubMed ID: 17563709
    [No Abstract]   [Full Text] [Related]  

  • 18. [Models of the lipid skin barrier].
    Toskić-Radojicić M
    Vojnosanit Pregl; 2002; 59(2):177-82. PubMed ID: 12053472
    [No Abstract]   [Full Text] [Related]  

  • 19. Breaching the skin barrier--insights from molecular simulation of model membranes.
    Notman R; Anwar J
    Adv Drug Deliv Rev; 2013 Feb; 65(2):237-50. PubMed ID: 22414344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations.
    Van Gele M; Geusens B; Brochez L; Speeckaert R; Lambert J
    Expert Opin Drug Deliv; 2011 Jun; 8(6):705-20. PubMed ID: 21446890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.